TFEB and neoplasm: A novel modulations of TFEB activity at the translation level has emerged, in which TFEB translation is suppressed by both of MA3 domains within programmed cell death 4, which is a tumor suppressor propitious to lysosome dysfunction related diseases (Chen et al., 2020).